Skip to content
Comparisons9 min readStandard

IV Ketamine vs At-Home Ketamine: Comparing Clinic and Home-Based Treatment

Compare IV ketamine vs at-home ketamine on cost, safety, supervision, and effectiveness, plus which option fits your health history and budget.

Ketamine Path Editorial Team··Reviewed by Ketamine Path Editorial Review
IV Ketamine vs At-Home Ketamine: Comparing Clinic and Home-Based Treatment article visual for Ketamine Path

Editorial review

Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.

IV Ketamine Infusions (In-Clinic)
VS
At-Home Ketamine Programs

IV ketamine and at-home ketamine differ in three main ways: how the medication enters your body, how closely a clinician watches you during treatment, and what you pay over a year of care. In the comparison of IV ketamine vs at-home ketamine, IV infusions deliver the drug directly into the bloodstream in a clinical setting with continuous monitoring, while at-home programs use sublingual ketamine, a tablet or lozenge dissolved under the tongue, prescribed after a telehealth evaluation and shipped from a licensed compounding pharmacy for self-administration under remote check-ins. Both formats have helped patients manage depression, anxiety, and other conditions, but the differences in supervision, evidence base, and cost are large enough to shape which one fits your situation. This guide compares IV ketamine vs at-home ketamine across effectiveness, safety, cost, and day-to-day experience, so you can weigh the tradeoffs against your medical needs, schedule, and budget. For firsthand accounts, read about the IV infusion experience and the oral ketamine experience from patients who tried each format.

Quick Answer

IV ketamine offers the largest evidence base and highest level of medical supervision but typically costs $6,000 to $14,000 or more per year and requires in-clinic visits. At-home ketamine uses lower-bioavailability sublingual medication with telehealth oversight and typically costs $1,800 to $4,800 per year. Patients with cardiovascular risk factors, severe or acute symptoms, or no prior ketamine screening history are generally better suited to IV infusions, while those who need affordability, privacy, or lack clinic access often do well with at-home programs. Some patients start with IV treatment and transition to at-home dosing for maintenance.

How Each Option Works

IV Ketamine Infusions

IV ketamine is administered directly into the bloodstream through an intravenous catheter placed by a nurse or physician at a specialized clinic. The clinician controls the infusion rate, typically delivering the medication over 40 to 60 minutes while monitoring vital signs continuously. The standard initial protocol involves six infusions spread over two to three weeks, followed by maintenance infusions as needed. See our guide to preparing for treatment for what a first infusion appointment involves.

At-Home Ketamine Programs

At-home programs pair you with a prescribing provider through telehealth, a clinical evaluation and prescription delivered by live video or phone rather than an in-person visit. The provider evaluates you, prescribes sublingual ketamine, and the medication ships from a licensed compounding pharmacy directly to your home. You self-administer the medication during scheduled sessions, usually with a telehealth check-in before or during the experience, and many programs require a treatment companion to be present. For a closer look at how the sublingual form compares to other oral options, see our oral vs. sublingual ketamine guide.

Effectiveness

IV infusions deliver ketamine with close to 100 percent bioavailability, the percentage of a drug that reaches the bloodstream in an active form and determines how much of a dose actually produces a therapeutic effect. That level of bioavailability allows for precise dosing and consistent plasma levels. The evidence base for IV ketamine is the largest of any administration route: response rates for treatment-resistant depression, major depressive disorder that has not adequately improved after at least two standard antidepressant trials, are consistently reported between 60 and 70 percent. According to a randomized controlled trial published in Archives of General Psychiatry, a single IV ketamine infusion produced a rapid antidepressant response in treatment-resistant patients, a 2006 finding that shaped how researchers study ketamine's effects today.

Sublingual ketamine has a bioavailability of roughly 25 to 35 percent, so higher nominal doses are needed to reach therapeutic levels. Fewer large clinical trials have focused specifically on sublingual ketamine compared with IV, but real-world data and emerging studies show meaningful response rates. Many patients achieve significant symptom improvement through at-home programs, though the evidence base is not yet as mature as it is for IV treatment. According to the National Institute of Mental Health, ketamine can ease depressive symptoms within hours for some patients, a far faster timeline than the several weeks standard antidepressants typically take to work.

Important

Blood pressure elevation is the most common medical concern during ketamine treatment. In a clinic, it can be detected and treated immediately. At home, it depends on accurate pre-treatment screening and having emergency protocols in place, so disclose your full cardiovascular history before starting either format.

Safety and Medical Supervision

IV Ketamine

In-clinic infusions provide the highest level of medical oversight. Vital signs are monitored throughout treatment, a clinician is physically present, and emergency equipment and medications are immediately available. This level of supervision makes IV infusions the more appropriate choice for patients with cardiovascular risk factors or complex medical histories.

At-Home Ketamine

At-home programs rely on thorough upfront screening and remote monitoring. During sessions, supervision may involve a live telehealth video check-in, a phone call, or an asynchronous check-in afterward. Reputable programs require a treatment companion to be present and provide emergency protocols, but the level of medical oversight is inherently lower than in a clinic. For patients without significant medical risk factors, prescribing clinicians generally consider this level of supervision appropriate. See our side effects and safety guide for what to watch for in either setting. At-home prescribing has also drawn regulatory attention as telehealth ketamine programs have expanded; for more on that, see our coverage of the federal review of online ketamine sellers.

Which Option Fits You

IV ketamine is generally the better fit if you have cardiovascular risk factors, a complex medical history, severe or acute symptoms, or no prior experience with ketamine screening and monitoring. The continuous, in-person supervision gives a clinician the ability to adjust the infusion or intervene immediately if your blood pressure or heart rate shifts outside a safe range.

At-home ketamine is generally the better fit if you have already been screened and stabilized, need a lower-cost option, live far from a specialized clinic, or value the privacy of dosing at home with a trusted companion present. It is not the right starting point for patients with unmanaged hypertension, cardiac disease, or a history of severe reactions to ketamine, since those situations call for the closer supervision a clinic provides.

Some patients use both formats over time, starting with a series of IV infusions to establish a response, then moving to at-home dosing for lower-cost maintenance once a clinician has confirmed the treatment is well tolerated. See our maintenance treatment guide for how that transition typically works.

Key Takeaway

The choice between IV and at-home ketamine usually comes down to how much medical supervision your health history requires and how much you can budget per year of care. Neither format is inherently better across the board; the right fit depends on your risk profile, access, and goals.

Questions to Ask Before You Choose

Whichever format you're considering, ask the clinic or telehealth provider these questions before you commit. Our guide to questions for continuity of care covers additional questions worth asking as treatment continues.

Action Checklist

  • Ask what monitoring happens during and immediately after dosing
  • Confirm the total annual cost, including screening, follow-ups, and lab work
  • Ask what the emergency protocol is if blood pressure or heart rate spikes
  • Ask where the medication is compounded and confirm the pharmacy's license
  • Ask whether a treatment companion is required and what their role covers
  • Ask how the initial protocol is structured and how maintenance dosing is scheduled

Read More Treatment Comparisons

See how other ketamine treatment formats and therapies stack up before you choose a program.

Frequently Asked Questions

Yes. Many patients complete an initial series of IV infusions, then transition to at-home sublingual dosing for maintenance once a clinician confirms they tolerate ketamine well and don't need continuous supervision.

The evidence base for at-home sublingual ketamine is smaller than for IV, and its lower bioavailability, about 25 to 35 percent versus close to 100 percent for IV, means higher nominal doses are needed to reach a therapeutic effect. Many patients still report meaningful symptom improvement, but head-to-head trial data comparing the two routes directly remains limited.

Coverage varies by plan and provider, and neither format has broad insurance coverage in the way FDA-approved esketamine treatment often does. Ask your clinic or telehealth provider directly about coverage and payment options before starting.

Reputable at-home programs screen for cardiovascular risk factors beforehand and require a treatment companion and an emergency protocol for the session. Discuss the specific plan with your prescribing provider before your first dose, and disclose your full cardiovascular history during screening.

Verdict

IV ketamine infusions offer higher bioavailability, more precise dosing, and direct medical supervision, making them the stronger clinical option for severe or treatment-resistant conditions. At-home ketamine programs provide significantly greater accessibility, lower cost, and convenience that make treatment realistic for patients who cannot access or afford in-clinic infusions. For many patients, starting with at-home treatment and escalating to IV if needed is a practical approach.

Share

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site